Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects

Clinical trial NCT01069367 · COMPLETED

Trial details

NCT number: NCT01069367
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Swine-Origin Influenza A H1N1 Virus

Start date: 2010-03-01
Primary completion: 2010-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.